In natural ecosystems and human societies, self-organized resource allocation and policy synergy are ubiquitous and significant. This work focuses on the synergy between Dual Reinforcement Learning Policies in the Minority Game (DRLP-MG) to optimize resource allocation. Our study examines a mixed-structured population with two sub-populations: a Q-subpopulation using Q-learning policy and a C-subpopulation adopting the classical policy. We first identify a synergy effect between these subpopulations. A first-order phase transition occurs as the mixing ratio of the subpopulations changes. Further analysis reveals that the Q-subpopulation consists of two internal synergy clusters (IS-clusters) and a single external synergy cluster (ES-cluster). The former contribute to the internal synergy within the Q-subpopulation through synchronization and anti-synchronization, whereas the latter engages in the inter-subpopulation synergy. Within the ES-cluster, the classical momentum strategy in the financial market manifests and assumes a crucial role in the inter-subpopulation synergy. This particular strategy serves to prevent long-term under-utilization of resources. However, it also trigger
The collaboration between humans and artificial intelligence (AI) holds the promise of achieving superior outcomes compared to either acting alone. Nevertheless, our understanding of the conditions that facilitate such human-AI synergy remains limited. A recent meta-analysis showed that, on average, human-AI combinations do not outperform the better individual agent, indicating overall negative human-AI synergy. We argue that this pessimistic conclusion arises from insufficient attention to human learning in the experimental designs used. To substantiate this claim, we re-analyzed all 74 studies included in the original meta-analysis, which yielded two new findings. First, most previous research overlooked design features that foster human learning, such as providing trial-by-trial outcome feedback to participants. Second, our re-analysis, using robust Bayesian meta-regressions, demonstrated that studies providing outcome feedback show relatively higher synergy than those without outcome feedback. Crucially, when feedback is paired with AI explanations we tend to find positive human-AI synergy, while AI explanations provided without feedback were strongly linked to negative synergy
Knowledge Graph Completion (KGC) fundamentally hinges on the coherent fusion of pre-trained entity semantics with heterogeneous topological structures to facilitate robust relational reasoning. However, existing paradigms encounter a critical "structural resolution mismatch," failing to reconcile divergent representational demands across varying graph densities, which precipitates structural noise interference in dense clusters and catastrophic representation collapse in sparse regions. We present SynergyKGC, an adaptive framework that advances traditional neighbor aggregation to an active Cross-Modal Synergy Expert via relation-aware cross-attention and semantic-intent-driven gating. By coupling a density-dependent Identity Anchoring strategy with a Double-tower Coherent Consistency architecture, SynergyKGC effectively reconciles topological heterogeneity while ensuring representational stability across training and inference phases. Systematic evaluations on two public benchmarks validate the superiority of our method in significantly boosting KGC hit rates, providing empirical evidence for a generalized principle of resilient information integration in non-homogeneous structured
Drug synergy is profoundly influenced by cellular context, as variations in protein interaction landscapes and pathway activities across cell types reshape how drugs act in combination. Most existing models overlook this heterogeneity, relying on static or bulk-level protein-protein interaction (PPI) networks that ignore cell-specific molecular wiring. The availability of large-scale transcriptomic data now enables the reconstruction of cell-line-resolved interactomes, offering a new foundation for contextualized drug synergy modeling. Here we present SynCell, a Contextualized Drug Synergy framework that integrates drug-protein, protein-protein, and protein-cell line relations within a unified graph architecture. SynCell leverages cell-line-specific PPI networks to embed the molecular context in which drugs act, and employs graph convolutional learning to model how pharmacological effects propagate through cell-specific signaling networks. This formulation treats synergy prediction as a cell-line-contextualized drug-drug interaction problem. Across the large-scale DrugCombDB benchmark, SynCell consistently outperforms state-of-the-art baselines - including DeepSynergy, HypergraphSy
Since its introduction in 2011, the partial information decomposition (PID) has triggered an explosion of interest in the field of multivariate information theory and the study of emergent, higher-order ("synergistic") interactions in complex systems. Despite its power, however, the PID has a number of limitations that restrict its general applicability: it scales poorly with system size and the standard approach to decomposition hinges on a definition of "redundancy", leaving synergy only vaguely defined as "that information not redundant." Other heuristic measures, such as the O-information, have been introduced, although these measures typically only provided a summary statistic of redundancy/synergy dominance, rather than direct insight into the synergy itself. To address this issue, we present an alternative decomposition that is synergy-first, scales much more gracefully than the PID, and has a straightforward interpretation. Our approach defines synergy as that information in a set that would be lost following the minimally invasive perturbation on any single element. By generalizing this idea to sets of elements, we construct a totally ordered "backbone" of partial synergy
The pursuit of optimizing cancer therapies is significantly advanced by the accurate prediction of drug synergy. Traditional methods, such as clinical trials, are reliable yet encumbered by extensive time and financial demands. The emergence of high-throughput screening and computational innovations has heralded a shift towards more efficient methodologies for exploring drug interactions. In this study, we present VQSynergy, a novel framework that employs the Vector Quantization (VQ) mechanism, integrated with gated residuals and a tailored attention mechanism, to enhance the precision and generalizability of drug synergy predictions. Our findings demonstrate that VQSynergy surpasses existing models in terms of robustness, particularly under Gaussian noise conditions, highlighting its superior performance and utility in the complex and often noisy domain of drug synergy research. This study underscores the potential of VQSynergy in revolutionizing the field through its advanced predictive capabilities, thereby contributing to the optimization of cancer treatment strategies.
Although synergy is an important concept that is strongly ingrained in games, it has not been widely discussed by the games community. This is due to the vagueness of the concept and the fact that there is no clear agreement on what it means. To solve this, we present a strict definition of what is synergy. Then we propose a methodology to use this definition to analyze synergy in games. Applying this definition to various games (Chess, League of Legends, and Magic: The Gathering), we illustrate how it can be used to solve many of the practical problems related to synergy.
The mechanisms driving different types of scientific innovation through collaboration remain poorly understood. Here we develop a comprehensive framework analyzing over 14 million papers across 19 disciplines from 1960 to 2020 to unpack how collaborative synergy shapes research disruption. We introduce the synergy factor to quantify collaboration cost-benefit dynamics, revealing discipline-specific architectures where Physics peaks at medium team sizes while humanities achieve maximal synergy through individual scholarship. Our mediation analysis demonstrates that collaborative synergy, not team size alone, mediates 75% of the relationship between team composition and disruption. Key authors play a catalytic role, with papers featuring exceptional researchers showing 561% higher disruption indices. Surprisingly, high-citation authors reduce disruptive potential while those with breakthrough track records enhance it, challenging traditional evaluation metrics. We identify four distinct knowledge production modes: elite-driven, baseline, heterogeneity-driven, and low-cost. These findings reveal substantial heterogeneity in optimal collaboration strategies across disciplines and provi
Multimodal Face Anti-Spoofing (FAS) methods, which integrate multiple visual modalities, often suffer even more severe performance degradation than unimodal FAS when deployed in unseen domains. This is mainly due to two overlooked risks that affect cross-domain multimodal generalization. The first is the modal representation invariant risk, i.e., whether representations remain generalizable under domain shift. We theoretically show that the inherent class asymmetry in FAS (diverse spoofs vs. compact reals) enlarges the upper bound of generalization error, and this effect is further amplified in multimodal settings. The second is the modal synergy invariant risk, where models overfit to domain-specific inter-modal correlations. Such spurious synergy cannot generalize to unseen attacks in target domains, leading to performance drops. To solve these issues, we propose a provable framework, namely Multimodal Representation and Synergy Invariance Learning (RiSe). For representation risk, RiSe introduces Asymmetric Invariant Risk Minimization (AsyIRM), which learns an invariant spherical decision boundary in radial space to fit asymmetric distributions, while preserving domain cues in an
Drug synergy prediction is a critical task in the development of effective combination therapies for complex diseases, including cancer. Although existing methods have shown promising results, they often operate as black-box predictors that rely predominantly on statistical correlations between drug characteristics and results. To address this limitation, we propose CausalDDS, a novel framework that disentangles drug molecules into causal and spurious substructures, utilizing the causal substructure representations for predicting drug synergy. By focusing on causal sub-structures, CausalDDS effectively mitigates the impact of redundant features introduced by spurious substructures, enhancing the accuracy and interpretability of the model. In addition, CausalDDS employs a conditional intervention mechanism, where interventions are conditioned on paired molecular structures, and introduces a novel optimization objective guided by the principles of sufficiency and independence. Extensive experiments demonstrate that our method outperforms baseline models, particularly in cold start and out-of-distribution settings. Besides, CausalDDS effectively identifies key substructures underlying
The knowledge base of an economy measured in terms of Triple Helix relations can be analyzed in terms of mutual information among geographical, sectorial, and size distributions of firms as dimensions of the probabilistic entropy. The resulting synergy values of a TH system provide static snapshots. In this study, we add the time dimension and analyze the synergy dynamics using the Norwegian innovation system as an example. The synergy among the three dimensions can be mapped as a set of partial time series and spectrally analyzed. The results suggest that the synergy at the level of both the country and its 19 counties shoe non-chaotic oscillatory behavior and resonates in a set of natural frequencies. That is, synergy surges and drops are non-random and can be analyzed and predicted. There is a proportional dependence between the amplitudes of oscillations and synergy values and an inverse proportional dependence between the oscillation frequencies' relative inputs and synergy values. This analysis of the data informs us that one can expect frequency-related synergy-volatility growth in relation to the synergy value and a shift in the synergy volatility towards the long-term fluc
Identifying motor synergies -- coordinated hand joint patterns activated at task-dependent time shifts -- from kinematic data is central to motor control and robotics. Existing two-stage methods first extract candidate waveforms (via SVD) and then select shifted templates using sparse optimization, requiring at least two datasets and complicating data collection. We introduce an optimization-based framework that jointly learns a small set of synergies and their sparse activation coefficients. The formulation enforces group sparsity for synergy selection and element-wise sparsity for activation timing. We develop an alternating minimization method in which coefficient updates decouple across tasks and synergy updates reduce to regularized least-squares problems. Our approach requires only a single data set, and simulations show accurate velocity reconstruction with compact, interpretable synergies.
Connecting conversation with external domain knowledge is vital for conversational recommender systems (CRS) to correctly understand user preferences. However, existing solutions either require domain-specific engineering, which limits flexibility, or rely solely on large language models, which increases the risk of hallucination. While Retrieval-Augmented Generation (RAG) holds promise, its naive use in CRS is hindered by noisy dialogues that weaken retrieval and by overlooked nuances among similar items. We propose ReGeS, a reciprocal Retrieval-Generation Synergy framework that unifies generation-augmented retrieval to distill informative user intent from conversations and retrieval-augmented generation to differentiate subtle item features. This synergy obviates the need for extra annotations, reduces hallucinations, and simplifies continuous updates. Experiments on multiple CRS benchmarks show that ReGeS achieves state-of-the-art performance in recommendation accuracy, demonstrating the effectiveness of reciprocal synergy for knowledge-intensive CRS tasks.
The advent of tiny artificial intelligence (AI) accelerators enables AI to run at the extreme edge, offering reduced latency, lower power cost, and improved privacy. When integrated into wearable devices, these accelerators open exciting opportunities, allowing various AI apps to run directly on the body. We present Synergy that provides AI apps with best-effort performance via system-driven holistic collaboration over AI accelerator-equipped wearables. To achieve this, Synergy provides device-agnostic programming interfaces to AI apps, giving the system visibility and controllability over the app's resource use. Then, Synergy maximizes the inference throughput of concurrent AI models by creating various execution plans for each app considering AI accelerator availability and intelligently selecting the best set of execution plans. Synergy further improves throughput by leveraging parallelization opportunities over multiple computation units. Our evaluations with 7 baselines and 8 models demonstrate that, on average, Synergy achieves a 23.0 times improvement in throughput, while reducing latency by 73.9% and power consumption by 15.8%, compared to the baselines.
Running is a fundamental form of human locomotion and a key task for evaluating neuromuscular control and lower-limb coordination. In recent years, muscle synergy analysis based on surface electromyography (sEMG) has become an important approach in this area. This review focuses on muscle synergies during running, outlining core neural control theories and biomechanical optimization hypotheses, summarizing commonly used decomposition methods (e.g., PCA, ICA, FA, NMF) and emerging autoencoder-based approaches. We synthesize findings on the development and evolution of running-related synergies across the lifespan, examine how running surface, speed, foot-strike pattern, fatigue, and performance level modulate synergy patterns, and describe characteristic alterations in populations with knee osteoarthritis, patellofemoral pain, and stroke. Current evidence suggests that the number and basic structure of lower-limb synergies during running are relatively stable, whereas spatial muscle weightings and motor primitives are highly plastic and sensitive to task demands, fatigue, and pathology. However, substantial methodological variability remains in EMG channel selection, preprocessing p
In recent years, end-to-end scene text spotting approaches are evolving to the Transformer-based framework. While previous studies have shown the crucial importance of the intrinsic synergy between text detection and recognition, recent advances in Transformer-based methods usually adopt an implicit synergy strategy with shared query, which can not fully realize the potential of these two interactive tasks. In this paper, we argue that the explicit synergy considering distinct characteristics of text detection and recognition can significantly improve the performance text spotting. To this end, we introduce a new model named Explicit Synergy-based Text Spotting Transformer framework (ESTextSpotter), which achieves explicit synergy by modeling discriminative and interactive features for text detection and recognition within a single decoder. Specifically, we decompose the conventional shared query into task-aware queries for text polygon and content, respectively. Through the decoder with the proposed vision-language communication module, the queries interact with each other in an explicit manner while preserving discriminative patterns of text detection and recognition, thus improv
In this paper, we present Synergy, a language model that bridges different levels of abstraction in an end-to-end fashion through a learned routing mechanism. Focusing on low-level linguistic abstraction, we trained our model as a byte-level language model. Our model spontaneously learns to tokenize bytes, producing fewer concept tokens than Byte-level Byte Pair Encoder (BBPE) tokenizers while keeping comparable performance. By comparing with Llama3, we observed an advantage of Synergy under the same model scale and training dataset size. Further studies show that the middle part (the higher abstraction part) of our model performs better when positional encodings are removed, suggesting the emergence of position-independent concepts. These findings demonstrate the feasibility of tokenizer-free architectures, paving the way for more robust and flexible pipelines.
This brief note considers the problem of estimating temporal synergy and integrated information in dyadic dynamical processes. One of the standard estimators of dynamic synergy is based on the minimal mutual information between sets of elements, however, despite it's increasingly widespread use, the mathematical features of this redundancy function have largely gone unexplored. Here, we show that it has two previously unrecognized limitations: it cannot disambiguate between truly integrated systems and disintegrated systems with first-order autocorrelation. Second, paradoxically, there are some systems that become more synergistic when dis-integrated (as long as first-order autocorrelations are preserved). In these systems, integrated information can decrease while synergy simultaneously increases. We derive conditions under which this occurs and discuss the implications of these findings for past and future work in applied fields such as neuroscience.
In this mini-review, we explore the new prediction methods for drug combination synergy relying on high-throughput combinatorial screens. The fast progress of the field is witnessed in the more than thirty original machine learning methods published since 2021, a clear majority of them based on deep learning techniques. We aim to put these papers under a unifying lens by highlighting the core technologies, the data sources, the input data types and synergy scores used in the methods, as well as the prediction scenarios and evaluation protocols that the papers deal with. Our finding is that the best methods accurately solve the synergy prediction scenarios involving known drugs or cell lines while the scenarios involving new drugs or cell lines still fall short of an accurate prediction level.
Drug synergy, characterized by the amplified combined effect of multiple drugs, is critically important for optimizing therapeutic outcomes. Limited data on drug synergy, arising from the vast number of possible drug combinations and testing costs, motivate the need for predictive methods. In this work, we introduce CongFu, a novel Conditional Graph Fusion Layer, designed to predict drug synergy. CongFu employs an attention mechanism and a bottleneck to extract local graph contexts and conditionally fuse graph data within a global context. Its modular architecture enables flexible replacement of layer modules, including readouts and graph encoders, facilitating customization for diverse applications. To evaluate the performance of CongFu, we conduct comprehensive experiments on four datasets, encompassing three distinct setups for drug synergy prediction. CongFu achieves state-of-the-art results on 11 out of 12 benchmark datasets, demonstrating its ability to capture intricate patterns of drug synergy. Through ablation studies, we validate the significance of individual layer components, affirming their contributions to overall predictive performance. Finally, we propose an explain